Atherectomy Devices Market to Grow at CAGR of 6.08% through 2029
Technological
advancements and rising demand for minimally invasive procedures is expected to
drive the Global Atherectomy Devices Market growth in the forecast period, 2025-2029.
According to
TechSci Research report, “Atherectomy Devices Market – Global Industry Size,
Share, Trends, Competition, Forecast & Opportunities, 2019-2029F”,
the Global Atherectomy Devices Market stood at USD 890.45 Million in 2023 and is
anticipated to project steady growth in the forecast period with a CAGR of 6.08% through 2029.
The Global
Atherectomy Devices Market is experiencing significant growth and evolution,
driven by several key factors. Atherectomy devices are instrumental in the
treatment of peripheral artery disease (PAD), a condition characterized by the
narrowing or blockage of arteries, typically in the legs. These devices are
designed to remove plaque buildup from arterial walls, restoring blood flow and
alleviating symptoms associated with PAD. One of the primary drivers of the
global atherectomy devices market is the increasing prevalence of PAD
worldwide. The rising incidence of lifestyle-related risk factors such as
obesity, diabetes, and smoking has contributed to a growing number of
individuals diagnosed with PAD. As a result, there is a heightened demand for
effective treatment options, including atherectomy devices, to manage this
debilitating condition.
Technological
advancements in atherectomy devices have also fueled market growth.
Manufacturers are continuously innovating to develop devices that offer
improved precision, safety, and efficacy in plaque removal. For example,
directional, rotational, laser, and orbital atherectomy devices utilize
different mechanisms of action to effectively remove plaque while minimizing
damage to surrounding tissues. These advancements have enhanced the procedural
success rates and patient outcomes, driving adoption among healthcare
providers.
The increasing
adoption of minimally invasive procedures for the treatment of PAD has
propelled the demand for atherectomy devices. Minimally invasive techniques
offer several advantages over traditional open surgeries, including reduced
risk of complications, shorter hospital stays, and quicker recovery times.
Atherectomy devices play a crucial role in these procedures by enabling precise
and controlled plaque removal, thereby facilitating safer and more efficient
interventions.
Another factor
driving the growth of the global atherectomy devices market is the growing
geriatric population. Aging populations are at a higher risk of developing PAD
due to age-related changes in blood vessels and higher prevalence of
comorbidities. As the elderly population continues to grow, especially in
developed countries, there is an increasing need for effective treatment
options for PAD, driving the demand for atherectomy devices.
Favorable
reimbursement policies and healthcare infrastructure developments in emerging
economies are contributing to market expansion. Governments and healthcare
organizations are increasingly recognizing the importance of PAD management and
are investing in healthcare infrastructure and reimbursement policies to
improve access to advanced treatment options, including atherectomy devices.
However, despite
the significant growth opportunities, the global atherectomy devices market
faces several challenges. One challenge is the high cost associated with
atherectomy procedures and devices, which may limit their adoption,
particularly in low- and middle-income countries where healthcare budgets are
constrained.
The availability
of alternative treatment options such as angioplasty and stenting may pose a
competitive threat to atherectomy devices. While atherectomy offers certain
advantages in specific patient populations, including those with heavily
calcified lesions, the choice of treatment modality depends on various factors,
including lesion characteristics, physician expertise, and patient preference.
Regulatory
challenges and stringent approval processes for atherectomy devices in some
regions may hinder market growth. Manufacturers must navigate complex
regulatory frameworks and demonstrate the safety and efficacy of their devices
through rigorous clinical trials and regulatory submissions, which can be
time-consuming and costly.
Concerns
regarding the long-term durability of atherectomy procedures and the potential
for restenosis or recurrence of arterial blockages remain significant clinical
considerations. While atherectomy devices effectively remove plaque, there is a
need for long-term data to assess the durability of treatment outcomes and
inform clinical decision-making.
The global
atherectomy devices market is witnessing robust growth driven by factors such
as the increasing prevalence of PAD, technological advancements, and the
growing adoption of minimally invasive procedures. However, challenges such as
cost constraints, competition from alternative treatments, regulatory hurdles,
and long-term efficacy concerns need to be addressed to sustain market growth
and meet the evolving needs of patients with PAD.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Atherectomy Devices Market”
The Global Atherectomy
Devices Market is segmented into product, application, end user, regional
distribution, and company.
Based on application,
the Peripheral segment emerges as the dominant category, accounting for a
significant share of the market. Peripheral atherectomy devices are
specifically designed to address arterial blockages in the peripheral vascular
system, which includes arteries outside of the heart and brain, primarily in the
lower extremities such as the legs. The dominance of
the Peripheral segment can be attributed to several factors. Peripheral artery
disease (PAD) represents a significant healthcare burden globally, affecting
millions of individuals, particularly the elderly population. PAD is
characterized by the narrowing or blockage of arteries in the legs due to the
buildup of plaque, leading to symptoms such as leg pain, claudication, and
impaired mobility. As PAD continues to be a prevalent condition, the demand for
effective treatment options such as peripheral atherectomy devices remains
high. Technological advancements in peripheral atherectomy devices have
contributed to their widespread adoption and utilization in clinical practice.
These devices utilize various mechanisms of action, including directional,
rotational, laser, and orbital atherectomy, to effectively remove plaque from
peripheral arteries while minimizing trauma to surrounding tissues. The
versatility and efficacy of these devices make them indispensable tools for
interventional cardiologists, vascular surgeons, and other healthcare
professionals treating patients with PAD.
Based on region,
Europe emerges as the second dominant region in the Global Atherectomy Devices
Market. This prominence can be attributed to several factors contributing to
the robust growth of atherectomy device adoption and utilization across the
region. Europe boasts a well-established healthcare infrastructure with
advanced medical facilities and a high level of healthcare expenditure. The
region is home to leading healthcare providers, academic institutions, and
research organizations that drive innovation and technological advancements in
medical devices, including atherectomy devices. This conducive environment
fosters the development and commercialization of cutting-edge atherectomy
technologies, attracting investment and driving market growth. The prevalence
of cardiovascular diseases, including peripheral artery disease (PAD), remains
significant across Europe, particularly among the aging population. PAD is a
major public health concern in Europe, contributing to a considerable burden of
morbidity and mortality. As healthcare providers strive to address the growing
prevalence of PAD and its associated complications, there is an increasing
demand for innovative treatment modalities such as atherectomy devices.
Major companies
operating in Global Atherectomy Devices Market are:
- Braun Melsungen AG
- Abbott Laboratories, Inc.
- Koninklijke Philips N.V.
- Boston Scientific Corporation
- Medtronic plc
- Becton, Dickinson, and Company
- Terumo Corporation
- Cardinal Health Inc.
- AngioDynamics Inc.
- Avinger Inc.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The future of
the Global Atherectomy Devices Market appears promising, driven by several key
factors shaping the healthcare landscape. Technological advancements and
innovations in atherectomy devices are anticipated to enhance procedural
outcomes, minimize procedural complications, and improve patient safety. Increasing
awareness about peripheral artery disease (PAD) and its associated risks,
coupled with the rising prevalence of cardiovascular diseases globally, is
expected to drive the demand for atherectomy procedures. Favorable
reimbursement policies, expanding healthcare infrastructure, and growing
investments in healthcare R&D are likely to fuel market growth. Strategic
collaborations and partnerships among industry players, healthcare providers,
and regulatory authorities are anticipated to facilitate product development,
regulatory approvals, and market expansion. Overall, the Global Atherectomy
Devices Market is poised for significant growth in the coming years, offering
promising opportunities for stakeholders across the healthcare continuum”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Atherectomy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Directional, Rotational, Laser, Orbital), By Application (Peripheral, Cardiovascular, Neurovascular), By End User (Hospitals & Surgical Centres, Ambulatory Care Centres, Others), By Region and Competition, 2019-2029F”,
has evaluated the future growth potential of Global Atherectomy Devices Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Atherectomy Devices Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com